{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:33:22Z","timestamp":1790548402588,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.cmi.2019.06.033","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T11:36:36Z","timestamp":1562931396000},"page":"51-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Unconventional diagnostic tests for Lyme borreliosis: a systematic review"],"prefix":"10.1016","volume":"26","author":[{"given":"A.","family":"Raffetin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Saunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bouiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Caraux-Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Eldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gallien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Jouenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Belkacem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Patey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Talagrand-Reboul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Jaulhac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Grillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.06.033_bib1","first-page":"1","article-title":"Surveillance for Lyme disease\u2014United States, 2008-2015","volume":"66","author":"Schwartz","year":"2017","journal-title":"Morb Mortal Wkly Rep Surveill Summ"},{"key":"10.1016\/j.cmi.2019.06.033_bib2","article-title":"Lyme borreliosis in Europe","volume":"16","author":"Rizzoli","year":"2011","journal-title":"Euro Surveill Bull"},{"key":"10.1016\/j.cmi.2019.06.033_bib3","first-page":"74","article-title":"An estimate of Lyme borreliosis incidence in Western Europe\u2020","volume":"39","author":"Sykes","year":"2017","journal-title":"J\u00a0Pub Health"},{"key":"10.1016\/j.cmi.2019.06.033_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","article-title":"Lyme borreliosis: clinical case definitions for diagnosis and management in Europe","volume":"17","author":"Stanek","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.06.033_bib5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/0128071-200809060-00002","article-title":"Skin manifestations of Lyme borreliosis: diagnosis and management","volume":"9","author":"M\u00fcllegger","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.cmi.2019.06.033_bib6","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/cid\/cix568","article-title":"Characteristics and clinical outcome of Lyme neuroborreliosis in a high endemic area, 1995\u20132014: a retrospective cohort study in Denmark","volume":"65","author":"Knudtzen","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib7","first-page":"615","article-title":"[Pain and neuroborreliosis: significance, diagnosis and treatment]","volume":"22","author":"Rupprecht","year":"2008","journal-title":"Schmerz Berl Ger"},{"key":"10.1016\/j.cmi.2019.06.033_bib8","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.pain.2014.04.024","article-title":"Acute and chronic pain associated with Lyme borreliosis: clinical characteristics and pathophysiologic mechanisms","volume":"155","author":"Zimering","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.cmi.2019.06.033_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/10408363.2018.1450353","article-title":"Laboratory diagnosis of Lyme borreliosis: current state of the art and future perspectives","volume":"55","author":"Lohr","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.cmi.2019.06.033_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12879-016-1468-4","article-title":"The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis","volume":"16","author":"Leeflang","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib11","article-title":"Cutaneous Lyme borreliosis: guideline of the German dermatology society","volume":"15","author":"Hofmann","year":"2017","journal-title":"Ger Med Sci"},{"key":"10.1016\/j.cmi.2019.06.033_bib12","first-page":"421","article-title":"Diagnosis and treatment of tick-borne diseases recommendations of the polish society of epidemiology and infectious diseases","volume":"69","author":"Pancewicz","year":"2015","journal-title":"Przegl Epidemiol"},{"key":"10.1016\/j.cmi.2019.06.033_bib13","series-title":"NICE guidelines","year":"2018"},{"key":"10.1016\/j.cmi.2019.06.033_bib14","first-page":"751","article-title":"Lyme neuroborreliosis","volume":"115","author":"Rauer","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.cmi.2019.06.033_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.medmal.2018.11.011","article-title":"Review of European and American guidelines for the diagnosis of Lyme borreliosis","volume":"49","author":"Eldin","year":"2019","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.cmi.2019.06.033_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmal.2019.05.001","article-title":"Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis","author":"Jaulhac","year":"2019","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.cmi.2019.06.033_bib17","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1128\/jcm.32.12.2980-2988.1994","article-title":"Detection of Borrelia burgdorferi sensu lato in lesional skin of patients with erythema migrans and acrodermatitis chronica atrophicans by ospA-specific PCR","volume":"32","author":"Moter","year":"1994","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.06.033_bib18","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1128\/JCM.36.9.2658-2665.1998","article-title":"Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis","volume":"36","author":"Brettschneider","year":"1998","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.06.033_bib19","first-page":"1","article-title":"Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification","author":"Lebech","year":"2002","journal-title":"APMIS Suppl"},{"key":"10.1016\/j.cmi.2019.06.033_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1574-695X.2006.00139.x","article-title":"Microbiological and serological diagnosis of Lyme borreliosis","volume":"49","author":"Wilske","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.cmi.2019.06.033_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199401273300401","article-title":"Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis","volume":"330","author":"Nocton","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2019.06.033_bib22","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/art.1780390505","article-title":"Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis","volume":"39","author":"Jaulhac","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cmi.2019.06.033_bib23","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1128\/JCM.00410-08","article-title":"Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis","volume":"46","author":"Cerar","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.06.033_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.idc.2007.12.005","article-title":"Lyme disease: laboratory issues","volume":"22","author":"Aguero-Rosenfeld","year":"2008","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.cmi.2019.06.033_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/14737159.2015.989837","article-title":"Lyme disease: diagnostic issues and controversies","volume":"15","author":"Aguero-Rosenfeld","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.cmi.2019.06.033_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168613","article-title":"The accuracy of diagnostic tests for Lyme disease in humans, a systematic review and meta-analysis of North American research","volume":"11","author":"Waddell","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.cmi.2019.06.033_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14737159.2016.1246959","article-title":"Progress in the molecular diagnosis of Lyme disease","volume":"17","author":"Ru\u017ei\u0107-Sablji\u0107","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.cmi.2019.06.033_bib28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.cmi.2019.06.033_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.cmi.2019.06.033_bib30","series-title":"Cochrane Handbook for systematic reviews of Interventions version 5.1.0","author":"Higgins","year":"2011"},{"key":"10.1016\/j.cmi.2019.06.033_bib31","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.cmi.2018.05.022","article-title":"Systematic reviews of diagnostic test accuracy in CMI","volume":"24","author":"Leeflang","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.06.033_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cmi.2018.06.011","article-title":"How to: evaluate a diagnostic test","volume":"25","author":"Leeflang","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.06.033_bib33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2019.06.033_bib34","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib35","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.187.4.655","article-title":"B\u00a0cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5","volume":"187","author":"Legler","year":"1998","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cmi.2019.06.033_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1074-7613(01)00257-6","article-title":"CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity","volume":"16","author":"Ansel","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.cmi.2019.06.033_bib37","first-page":"74","article-title":"CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients","volume":"265","author":"Wagner","year":"2018","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.cmi.2019.06.033_bib38","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1128\/IAI.01642-06","article-title":"Borrelia garinii induces CXCL13 production in human monocytes through toll-like receptor 2","volume":"75","author":"Rupprecht","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2019.06.033_bib39","first-page":"247","article-title":"Neuroborreliosis","volume":"245","author":"Kaiser","year":"1998","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.cmi.2019.06.033_bib40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/jir.2016.0101","article-title":"Chemokine CXC Ligand 13 in cerebrospinal fluid can be used as an early diagnostic biomarker for Lyme neuroborreliosis: a meta-analysis","volume":"37","author":"Yang","year":"2017","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.cmi.2019.06.033_bib41","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.cmi.2018.04.007","article-title":"Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systemic review and meta-analysis","volume":"24","author":"Rupprecht","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.06.033_bib42","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ttbdis.2018.04.008","article-title":"CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA","volume":"9","author":"Markowicz","year":"2018","journal-title":"Ticks Tick-Borne Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib43","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.diagmicrobio.2018.02.013","article-title":"Point-of-care testing for CXCL13 in Lyme neuroborreliosis","volume":"91","author":"Pietik\u00e4inen","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib44","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/01.wnl.0000171349.06645.79","article-title":"The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis","volume":"65","author":"Rupprecht","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.cmi.2019.06.033_bib45","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00115-005-2021-7","article-title":"[Cytokine CXCL13-a possible early CSF marker for neuroborreliosis]","volume":"77","author":"Rupprecht","year":"2006","journal-title":"Nervenarzt"},{"key":"10.1016\/j.cmi.2019.06.033_bib46","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/jnnp.2009.195438","article-title":"The chemokine CXCL13 in acute neuroborreliosis","volume":"81","author":"Senel","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.cmi.2019.06.033_bib47","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1212\/01.wnl.0000269672.17807.e0","article-title":"Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients","volume":"69","author":"Blanc","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.cmi.2019.06.033_bib48","first-page":"630","article-title":"Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis","volume":"259","author":"Djukic","year":"2012","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.cmi.2019.06.033_bib49","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/CVI.00071-16","article-title":"CCL19 as a chemokine risk factor for posttreatment Lyme disease syndrome: a prospective clinical cohort study","volume":"23","author":"Aucott","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2019.06.033_bib50","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/infdis\/jiv310","article-title":"A\u00a0highly expressed human protein, Apolipoprotein B-100, serves as an autoantigen in a subgroup of patients with Lyme disease","volume":"212","author":"Crowley","year":"2015","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib51","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/cid\/cix002","article-title":"T-Helper 17 cell cytokine responses in Lyme disease correlate with Borrelia burgdorferi antibodies during early infection and with autoantibodies late in the illness in patients with antibiotic-refractory Lyme arthritis","volume":"64","author":"Strle","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib52","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.37732","article-title":"A\u00a0novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease","volume":"65","author":"Drouin","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cmi.2019.06.033_bib53","first-page":"S437","article-title":"Identification of annexin A2 as an autoantigen in rheumatoid arthritis and in Lyme arthritis","volume":"66","author":"Pianta","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.cmi.2019.06.033_bib54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-115-7-533","article-title":"The T-cell proliferative assay in the diagnosis of Lyme disease","volume":"115","author":"Dressler","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2019.06.033_bib55","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM198812013192203","article-title":"Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi","volume":"319","author":"Dattwyler","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2019.06.033_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.1780340404","article-title":"T\u00a0cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation","volume":"34","author":"Krause","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cmi.2019.06.033_bib57","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/art.1780340611","article-title":"T\u00a0cell responses to polypeptide fractions of Borrelia burgdorferi in patients with Lyme arthritis","volume":"34","author":"Yoshinari","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cmi.2019.06.033_bib58","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archderm.1995.01690180047008","article-title":"Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea","volume":"131","author":"Buechner","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cmi.2019.06.033_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.diagmicrobio.2006.06.008","article-title":"A\u00a0novel lymphocyte transformation test (LTT-MELISA) for Lyme borreliosis","volume":"57","author":"Valentine-Thon","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib60","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1874205X01206010104","article-title":"The lymphocyte transformation test for Borrelia detects active Lyme borreliosis and verifies effective antibiotic treatment","volume":"6","author":"von Baehr","year":"2012","journal-title":"Open Neurol J"},{"key":"10.1016\/j.cmi.2019.06.033_bib61","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7326\/0003-4819-114-4-285","article-title":"Lymphoproliferative responses to Borrelia burgdorferi in Lyme disease","volume":"114","author":"Zoschke","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2019.06.033_bib62","first-page":"5890","article-title":"Diagnostic use of the lymphocyte transformation test-memory lymphocyte immunostimulation assay in confirming active Lyme borreliosis in clinically and serologically ambiguous cases","volume":"7","author":"Puri","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.cmi.2019.06.033_bib63","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF01646998","article-title":"Long-term persistence of specific T- and B-lymphocyte responses to Borrelia burgdorferi following untreated neuroborreliosis","volume":"18","author":"Kr\u00fcger","year":"1990","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2019.06.033_bib64","series-title":"Borr\u00e9liose de Lyme et autres maladies vectorielles \u00e0 tiques (MVT). Texte des recommandations","author":"Haute Autorit\u00e9 de Sant\u00e9 (HAS)","year":"2018"},{"key":"10.1016\/j.cmi.2019.06.033_bib65","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cmi.2017.08.025","article-title":"To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis","volume":"24","author":"Dessau","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.06.033_bib66","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-3083.1995.tb03713.x","article-title":"Lyme neuroborreliosis: evidence for persistent up-regulation of Borrelia burgdorferi-reactive cells secreting interferon-\u03b3","volume":"42","author":"Wang","year":"1995","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cmi.2019.06.033_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01695-17","article-title":"An enzyme-linked immunosorbent spot assay measuring Borrelia burgdorferi B31-specific interferon \u03b3-secreting T cells cannot discriminate active Lyme neuroborreliosis from past Lyme borreliosis: a prospective study in The Netherlands","volume":"56","author":"van Gorkom","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.06.033_bib68","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/cells2030607","article-title":"An enhanced ELISPOT assay for sensitive detection of antigen-specific T cell responses to Borrelia burgdorferi","volume":"2","author":"Jin","year":"2013","journal-title":"Cells"},{"key":"10.1016\/j.cmi.2019.06.033_bib69","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/cid\/ciw112","article-title":"Detection of IFN-\u03b3 secretion by T cells collected before and after successful treatment of early Lyme disease","volume":"62","author":"Callister","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib70","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/cells1020153","article-title":"Can ELISPOT be applied to a clinical setting as a diagnostic utility for neuroborreliosis?","volume":"1","author":"Nordberg","year":"2012","journal-title":"Cells"},{"key":"10.1016\/j.cmi.2019.06.033_bib71","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2249.1995.tb03134.x","article-title":"The outer surface proteins of Lyme disease Borrelia spirochetes stimulate T cells to secrete interferon-\u03b3 (IFN-\u03b3): diagnostic and pathogenic implications","volume":"101","author":"Forsberg","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cmi.2019.06.033_bib72","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1086\/382893","article-title":"Borrelia-specific interferon-\u03b3 and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome","volume":"189","author":"Widhe","year":"2004","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib73","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.1365-2249.1999.00840.x","article-title":"Asymptomatic Borrelia-seropositive individuals display the same incidence of Borrelia-specific interferon-\u03b3 (IFN-\u03b3) -secreting cells in blood as patients with clinical Borrelia infection","volume":"115","author":"Ekerfelt","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cmi.2019.06.033_bib74","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1046\/j.1523-1747.2000.00198.x","article-title":"Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans","volume":"115","author":"M\u00fcllegger","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.cmi.2019.06.033_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018220","article-title":"Decreased Th1-type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans","volume":"6","author":"Sj\u00f6wall","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.cmi.2019.06.033_bib76","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/art.22441","article-title":"High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory Lyme arthritis","volume":"56","author":"Shin","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cmi.2019.06.033_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(97)00118-5","article-title":"Compartmentalization of antigen specific cytokine responses to the central nervous system in CNS borreliosis: secretion of IFN-\u03b3 predominates over IL-4 secretion in response to outer surface proteins of Lyme disease Borrelia spirochetes","volume":"79","author":"Ekerfelt","year":"1997","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.cmi.2019.06.033_bib78","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/CVI.00353-13","article-title":"Diagnostic value of cytokines and chemokines in Lyme neuroborreliosis","volume":"20","author":"Cerar","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2019.06.033_bib79","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2012.10.011","article-title":"Increased IFN\u03b1 activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits","volume":"255","author":"Jacek","year":"2013","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.cmi.2019.06.033_bib80","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-2478(00)00316-3","article-title":"Decreased CD57 lymphocyte subset in patients with chronic Lyme disease","volume":"76","author":"Stricker","year":"2001","journal-title":"Immunol Lett"},{"key":"10.1016\/j.cmi.2019.06.033_bib81","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/CVI.00167-09","article-title":"Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls","volume":"16","author":"Marques","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2019.06.033_bib82","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fimmu.2013.00422","article-title":"Functional significance of CD57 expression on human NK cells and relevance to disease","volume":"4","author":"Nielsen","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2019.06.033_bib83","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/cid\/cit939","article-title":"Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study","volume":"58","author":"Marques","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib84","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/cid\/cit942","article-title":"Editorial commentary: xenodiagnosis for posttreatment Lyme disease syndrome: resolving the conundrum or adding to it?","volume":"58","author":"Bockenstedt","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib85","doi-asserted-by":"crossref","first-page":"11383","DOI":"10.1021\/acs.analchem.5b02803","article-title":"Quantification of Borrelia burgdorferi membrane proteins in human serum: a new concept for detection of bacterial infection","volume":"87","author":"Cheung","year":"2015","journal-title":"Anal Chem"},{"key":"10.1016\/j.cmi.2019.06.033_bib86","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12967-015-0701-z","article-title":"Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis","volume":"13","author":"Magni","year":"2015","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.cmi.2019.06.033_bib87","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1099\/00222615-23-3-261","article-title":"Demonstration of spirochaetes in patients with Lyme disease with a modified silver stain","volume":"23","author":"de Koning","year":"1987","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.cmi.2019.06.033_bib88","first-page":"26","article-title":"Lyme arthritis. spirochetes found in synovial microangiopathic lesions","volume":"118","author":"Johnston","year":"1985","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cmi.2019.06.033_bib89","first-page":"179","article-title":"Diagnosis of Lyme disease by demonstration of spirochetes in tissue biopsies","volume":"263","author":"de Koning","year":"1986","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg A"},{"key":"10.1016\/j.cmi.2019.06.033_bib90","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archderm.1984.01650440047017","article-title":"Erythema chronicum migrans of Lyme disease","volume":"120","author":"Berger","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cmi.2019.06.033_bib91","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1309\/3369XXFPEQUNEP5C","article-title":"Focus floating microscopy: \u201cgold standard\u201d for cutaneous borreliosis?","volume":"127","author":"Eisendle","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cmi.2019.06.033_bib92","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/art.1780380820","article-title":"Lyme disease in a 74-year-old forest owner with symptoms of dermatomyositis","volume":"38","author":"Hoffmann","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cmi.2019.06.033_bib93","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/infdis\/160.1.150","article-title":"Demonstration of spirochetes in cardiac biopsies of patients with Lyme disease","volume":"160","author":"de Koning","year":"1989","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib94","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00000372-198304000-00009","article-title":"The spirochete in erythema chronicum migrans. Demonstration by light and electron microscopy","volume":"5","author":"Waldo","year":"1983","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.cmi.2019.06.033_bib95","first-page":"64","article-title":"Laboratory confirmation of Lyme disease","volume":"2","author":"Schwan","year":"1991","journal-title":"Can J Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib96","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CMR.18.3.484-509.2005","article-title":"Diagnosis of Lyme borreliosis","volume":"18","author":"Aguero-Rosenfeld","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2019.06.033_bib97","first-page":"15","article-title":"A\u00a0simple method for the detection of live Borrelia spirochaetes in human blood using classical microscopy techniques","volume":"3","author":"Laane","year":"2013","journal-title":"Biol Biomed Rep"},{"key":"10.1016\/j.cmi.2019.06.033_bib98","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/23744235.2016.1144931","article-title":"Validate or falsify: lessons learned from a microscopy method claimed to be useful for detecting Borrelia and Babesia organisms in human blood","volume":"48","author":"Aase","year":"2016","journal-title":"Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib99","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10096-014-2217-5","article-title":"Evaluation of two commercially available rapid diagnostic tests for Lyme borreliosis","volume":"34","author":"Smit","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.033_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/srep35069","article-title":"Microfluidics-based point-of-care test for serodiagnosis of Lyme disease","volume":"6","author":"Nayak","year":"2016","journal-title":"Sci Rep"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1930388X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1930388X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:24:04Z","timestamp":1761117844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X1930388X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1198743X1930388X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.06.033","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unconventional diagnostic tests for Lyme borreliosis: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}